Clinical Trial Update: Docetaxel in Head and Neck Cancer [Phase 2, Phase 3]

View source ↗

Summary

Sanofi conducted a Phase 2/3 trial of Docetaxel in head and neck cancer. The study status is completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Head and Neck Cancer

Drugs mentioned

• DOCETAXEL (DOCETAXEL)

Snippet

Sponsor: Sanofi | Conditions: Head and Neck Neoplasms | Phase 2, Phase 3 | Status: COMPLETED